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Inflammasome is a cytosolic multiprotein complex to activate caspase-1 leading to the subsequent processing of 
inactive pro-interleukin-1-beta (Pro-IL-1β) into its active interleukin-1 beta (IL-1β) in response to pathogen- or danger-
associated molecular pattern. In recent years, a huge progress has been made to identify inflammasome component as a 
molecular platform to recruit and activate caspase-1. Nucleotide-binding oligomerization domain-like receptor (NLR) 
family proteins such as NLRP1, NLRP3 or interleukin-1β-converting enzyme (ICE)-protease activating factor (IPAF) 
have been first characterized to form inflammasome complex to induce caspase-1 activation. More recently, non-NLR 
type, pyrin-domain (PYD)-containing proteins such as pyrin or absent in melanoma2 (AIM2) were also proposed to 
form caspase-1-activating inflammasome machinery with apoptosis-associated speck-like protein containing a CARD 
(ASC), an essential adaptor molecule. Inflammasome pathways were shown to be crucial for protecting host organisms 
against diverse pathogen infections, but accumulating evidences also suggest that excessive activation of inflammasome/ 
caspase-1 might be related to the pathogenesis of inflammation-related diseases. Indeed, mutations in NLRP3 or pyrin are 
closely associated with autoinflammatory diseases such as familial Mediterranean fever (FMF) syndrome or Muckle-Wells 
syndrome (MWS), indicating that the regulation of caspase-1 activity by inflammasome is a central process in these 
hereditary inflammatory disorders. Here, recent advances on the molecular mechanism of caspase-1 activation by 
PYD-containing inflammasomes are summarized and discussed. 
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Pattern-recognition receptors 
 
Innate immune system is highly conserved among 
species from plants to mammals and offers the first line of 
host defense against invading pathogens. Upon microbial 
infection, innate immune system recognizes the invasion of 
microbes by germline-encoded pathogen-recognition or 
pattern-recognition receptors (PRRs) (1) (Fig. 1). As far, 
four different PRR families have been identified such as 
Toll-like receptor (TLR), retinol-inducible gene-I (RIG-I)-
like receptor (RLR), C-type lectin receptor (CLR) and 
nucleotide-binding oligomerization domain (NOD)-like 
receptor (NLR). These PRRs are predominantly expressed 
in innate immune cells including macrophages or dendritic 
cells, where they sense a unique pattern of microbial 
component, called pathogen-associated molecular pattern 
(PAMP). 
The best-characterized PRR is a membrane-spanning 
Toll-like receptor (TLR) family, localized on the plasma or 
endosomal membrane. TLRs contain outward leucine-rich 
repeat (LRR) region, which specifically bind to PAMP, and 
cytoplasmic Toll/interleukin-1 receptor homology (TIR) 
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domain for protein-protein interaction. To date, 10 human 
and 12 mouse TLR members have been identified, and 
each TLR detects a specific microbial moiety such as viral 
single-stranded RNA (ssRNA) or double-stranded RNA 
(dsRNA), unmethylated CpG DNA motifs and bacterial 
lipopolysaccharide (LPS), lipoprotein, lipopeptide or peptido- 
glycan (PGN) through its LRR motif (2). 
Upon engagement of specific ligand, TLRs trigger a set of 
downstream signaling pathways via recruiting TIR domain-
containing adaptor molecules such as myeloid differentiation 
primary response gene 88 (MyD88), MyD88-adaptor-like 
(MAL/TIRAP), TIR-domain-containing adaptor protein-
inducing interferon-β (TRIF/TICAM1) and TRIF-related 
adaptor molecule (TRAM/TICAM2) (3, 4). These diverse 
TLR-mediated signaling cascades ultimately activate two 
transcription factors such as interferon regulatory factor 
(IRF) and nuclear factor-kappa B (NF-κB), leading to the 
induction of type I interferon (IFN) including IFNα or 
IFNβ, proinflammatory cytokines and the maturation of 
dendritic cell (1, 4). 
Unlike TLRs, the other PRRs, including RLR and NLR 
family, are cytoplasmic receptors for sensing an intracellular 
PAMP (1, 5). While endosomal TLRs recognize microbial 
nucleic acids, such as dsRNA (TLR3), ssRNA (TLR7/8) 
and unmethylated CpG DNA (TLR9), RLR families, RIG-I 
and melanoma differentiation-associated gene 5 (MDA5), 
are specialized in detecting intracellular viral dsRNA through 
their RNA helicase domain (6). Upon sensing cytoplasmic 
dsRNA, RLRs interact with mitochondrial antiviral signaling 
protein (MAVS), also known as interferon-beta promoter 
stimulator 1 (IPS-1), Cardif and virus-induced signaling 
adaptor (VISA), through caspase recruitment domain 
Figure 1. Pattern-recognition receptor (PRR) signaling pathways. Three classes of PRR families, such as TLRs, RLRs and NLRs, 
sense microbial products or endogenous danger signals to trigger downstream signaling pathways, resulting in the production of type I IFN,
proinflammatory cytokines and the activation of caspase-1. 
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(CARD) homotypic interaction (1). Association of RIG-I 
with MAVS then triggers a series of downstream signaling 
cascade leading to the induction of antiviral type I IFN and 
proinflammatory cytokines as similar to TLR-mediated 
signaling pathways (7). 
On the other hand, the main function of NLRs, another 
type of intracellular PRR family, has been considered to 
activate caspase-1 in response to PAMP or danger-associated 
molecular pattern (DAMP) (8). Although it is not clarified 
in detail how NLRs sense PAMP or DAMP, the engagement 
of pathogenic moiety to NLRs might trigger the formation 
of molecular complex comprising of NLR, apoptosis-
associated speck-like protein containing a CARD (ASC) 
and procaspase-1, resulting in the activation of caspase-1. 
This molecular assembly to activate caspase-1 is termed as 
inflammasome complex (9). NLR contains N-terminal 
CARD, pyrin domain (PYD) or baculovirus inhibitor of 
apoptosis repeat (BIR), followed by central NAIP, CIITA, 
HET-E, TP-1 (NACHT) domain and C-terminal LRR motif 
(5). In addition to NLR family, another PYD-containing 
proteins such as pyrin and absent in melanoma2 (AIM2) 
were also identified to assemble inflammasome complex 
with ASC, resulting in the activation of caspase-1 (10~14). 
Here, we will describe the molecular function of PYD- 
containing inflammasomes in innate immune system. 
 
Caspase-1: Inflammatory caspase 
 
Caspase-1, also known as interleukin-1β-converting 
enzyme (ICE), belongs to a cysteine protease caspase family, 
which mainly orchestrate the molecular event of cellular 
apoptosis or inflammation. To date, 14 caspases have been 
identified in human and mouse, and they are classified into 
two subgroups according to their function as inflammatory 
(Group I) or apoptotic (Group II or III) caspases (15). 
Inflammatory caspases include caspase-1, -4 and -5 in 
human and caspase-1, -11 and -12 in mouse, and they are 
clustered on human chromosome 11q22 and mouse chro- 
mosome 9A1 (16). Caspase-1 is responsible for processing 
pro-interleukin 1β (pro-IL-1β), pro-IL-18 and pro-IL-33 
into their matured form, but the physiological functions of 
the other inflammatory caspases except caspase-1 are poorly 
characterized yet. 
The significance of caspase-1 in innate immune protection 
was highlighted using caspase-1 knockout mice study. For 
example, deficiency of caspase-1 conferred resistance to 
lipopolysaccharide (LPS)-induced shock, whereas mice 
lacking both IL-1β and IL-18 are still susceptible (17, 18). 
Recent studies also demonstrated that caspase-1-deficient 
mice are more susceptible to the infection of bacterial 
pathogen such as Francisella tularensis and Salmonella 
enterica than wild type mice (19, 20). These results 
collectively indicate that caspase-1 is crucial component in 
regulating endotoxin-induced inflammation and clearance 
of intracellular bacterial pathogens. 
In addition to the maturation of IL-1β, caspase-1 seems 
to regulate more noncanonical processes contributing into 
innate immune responses, based on the phenotypic differ- 
ences between caspase-1 and IL-1β or IL-18 knockout 
mice studies. Caspase-1 might regulate the unconventional 
secretion of leaderless proinflammatory proteins such as 
IL-1β and high-mobility group box 1 (HMGB1), although 
the molecular mechanism remains largely unknown (18, 
21). Furthermore, caspase-1 induces pyroptotic cell death 
in macrophages and dendritic cells in response to microbial 
infection, probably to clear the infected cells (21). Further 
study will be needed to clarify the molecular mechanism 
by which caspase-1 regulates these noncanonical functions. 
Like all other apical caspases, caspase-1 is synthesized 
as an inactive zymogen, which contains N-terminal CARD 
domain, followed by p20 and p10 domain. To gain its full 
activity, procaspase-1 has to be recruited to molecular 
platform and auto-processed by proximity model into 
heterotetrameric structure of p20 and p10 (22, 23). Attempts 
to find a CARD-containing protein, which specifically binds 
to CARD of procaspase-1, first uncovered two proteins, 
which are able to interact with procaspase-1 to induce its 
processing, namely ASC and ICE-protease activating factor 
(IPAF/NLRC4) (24, 25). 
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ASC: a key adaptor molecule for caspase-1 
activation and pyroptotic cell death 
 
ASC is a bipartite protein containing N-terminal PYD 
and C-terminal CARD, which engages procaspase-1 via 
CARD homotypic interaction. Interestingly, overexpression 
or enforced oligomerization of ASC is sufficient to activate 
caspase-1 and the subsequent maturation of IL-1β, indicating 
that the oligomerization of ASC is a crucial event to induce 
the activation of caspase-1 (24, 26, 27). In a physiological 
condition, ASC requires an additional PYD-containing 
protein for triggering the oligomerization of ASC (Fig. 2). 
Protein data base search to find a PYD-containing protein 
to engage and oligomerize ASC sheds light on the identi- 
fication of caspase-1-activating molecular machinery such 
as NLRP3, pyrin and AIM2, all of which are able to 
interact with ASC through PYD-PYD homotypic interaction 
to assemble inflammasome complex (Fig. 2). Moreover, 
accumulating ASC-deficient mice studies confirmed that 
ASC is an essential molecular adaptor protein to activate 
caspase-1 in response to a variety of stimuli (19, 28~32). 
PYD belongs to death domain superfamily, which is 
characterized by 6 α-helix bundle and plays an important 
role in the assembly of apoptotic and inflammatory proteins 
(33). Based on the nuclear magnetic resonance (NMR) 
structural analysis on the PYD of NLRP1 and ASC, PYD 
has a unique long loop region between H2 and H3 helices 
or at H3, which may determine specificity of PYD (33~35). 
Although the structural mode of PYD-PYD interaction is 
not characterized yet, structural and mutational analysis on 
the PYD of ASC revealed that charged and hydrophobic 
Figure 2. PYD-containing inflammasome pathways. Inactive PYD-containing inflammasome components are activated by sensing 
diverse microbial infection or danger signals (NLRP3), cytoplasmic dsDNA (AIM2) and autoinflammatory disease-associated PSTPIP1 
mutant (pyrin) to trigger the formation of ASC pyroptosome, resulting in the activation of caspase-1. 
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residue in H2 and H3 plays a critical role in homotypic or 
heterotypic PYD interaction (36). 
A number of PYD-containing proteins to associate with 
ASC have been reported to activate or inhibit caspase-1 
activity suggesting ASC is a hub molecule in the regulation 
of caspase-1/inflammasome pathway. While PYD-containing 
proteins equipped with self-oligomerizing domain generally 
activates caspase-1, cytosolic or viral PYD-only protein 
such as PYD-only protein 1 (POP1) or POP2 and M13L 
has been shown to inhibit ASC-mediated caspase-1 or NF-
κB activation through PYD-PYD interaction (37~39). 
ASC is highly oligomerized into form ASC pyroptosome 
(Fig. 2), a supramolecular assembly of ASC, responding 
to a variety of proinflammatory stimuli. Interestingly, the 
macrophages containing ASC pyroptosome rapidly undergo 
caspase-1-dependent inflammatory cell death, called pyrop- 
tosis (27, 40). Indeed, overexpression or oligomerization 
of ASC is already known to induce apoptosis although 
detailed molecular mechanism is not fully understood (41, 
42). ASC, also known as target of methylation-induced 
silencing (TMS1), is frequently silenced by abberant 
methylation in several tumor cell types (43, 44) and induced 
in a p53-dependent manner (42). It will be thus of interest 
to investigate the role of ASC or inflammasome-mediated 
cell death in developing these tumors. 
 
NLR subfamily 
 
To date, more than 20 NLR members have been identified 
and grouped into five different subfamilies mainly based 
on its N-terminal moiety, which are NLRA (CIITA), NLRB 
(NAIP), 5 NLRC, 14 NLRP and NLRX (45). Among NLRC 
subfamilies, which contain N-terminal CARD, only IPAF 
(NLRC4) has been clearly shown to assemble inflam- 
masome complex leading to the activation of caspase-1 
and the maturation of IL-1β upon infection with Gram-
negative bacterial pathogen such as Salmonella typhimurium 
and Shigella flexneri (28, 46~48). IPAF could associate 
directly with procaspase-1 through direct CARD-CARD 
interaction. However, it is poorly understood whether ASC 
is required for IPAF inflammasome-induced caspase-1 
activation, because ASC-deficient mice also showed a 
defect in caspase-1 activation in response to S. typhimurium 
infection (28). 
Contrary to ICE-protease activating factor (IPAF), two 
NLRC proteins, NOD1 (NLRC1) and NOD2 (NLRC2), 
have been shown to activate NF-κB signaling by recognizing 
the specific motif of bacterial peptidoglycans, indicating 
that NLRC might cooperate with TLR to defend host cells 
against bacterial infections (49). Intriguingly, another NLRC 
subfamily protein, NLRC5 was recently proposed to inhibit 
not only NF-κB signaling via interacting with IKKα and 
IKKβ, but type I IFN signaling via associating with RIG-I 
and MDA5, suggesting that NLRC5 might regulate TLR- 
or RLR-mediated innate immune signaling pathways (50). 
However, deficiency of NLRC5 failed to confer the differ- 
ences in the secretion of proinflammatory cytokine or type 
I IFN upon viral or bacterial infections (51). As NLRC5 
was rather proposed to activate NLRP3 inflammasome (52), 
further study will be needed to elucidate the physiological 
function of NLRC5 in innate immune system. 
NLRP subfamilies, which contain N-terminal PYD, has 
been widely regarded as a major inflammasome component 
to activate caspase-1 by way of association with ASC. 
NLRP1 (also known as NALP1, CARD7) is the first pro- 
posed inflammasome, which forms complex with caspase-1, 
caspase-5, ASC and cardinal (9), but its detailed molecular 
mechanism to activate caspase-1 is still poorly understood. 
NLRP1 was demonstrated to activate caspase-1 in cell free 
system upon stimulation with muramyl dipeptide (MDP) 
and ATP (53), and mouse Nlrp1b was shown to play a 
crucial role in Bacillus anthracis lethal toxin-induced 
caspase-1 activation and macrophage cell death in mouse 
(54). However, physiological role of human NLRP1 to 
activate caspase-1 is not characterized yet. Nevertheless, 
genetic variations in NLRP1 are associated with vitiligo-
associated autoimmune or autoinflammatory diseases 
indicating NLRP1 may play a crucial role in the patho- 
genesis of these inflammatory disorders (55). 
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NLRP3 inflammasome 
 
NLRP3 (previously known as NALP3, cryopyrin or 
PYPAF1) is currently the most well-defined inflammasome 
to activate caspase-1 in an ASC-dependent manner upon 
stimulation with a variety of microbial infection and host-
derived danger signal (29~32, 56~58). Interest has been 
initially focused on the protective role of NLRP3 inflam- 
masome to recognize PAMPs derived from invading micro- 
bial pathogens including bacteria producing pore-forming 
toxin, viruses and fungi (49). Although NLRP3-deficient 
mice exhibited a defect in caspase-1 activation and IL-1β 
secretion upon infection with the pathogens such as Listeria 
monocytogenes, Staphylococcus aureus, influenza virus, 
adenovirus and Candida albicans, it remains to be deter- 
mined how NLRP3 senses these wide range of pathogen-
derived signals. Instead, emerging evidences have proposed 
that NLRP3 is also the crucial player to trigger sterile 
inflammatory responses in response to a variety of host-
derived signals from tissue injury or metabolic stress (5, 
59). NLRP3 inflammasome is obviously responsible for 
detecting endogenous indicators of cellular danger signal 
such as extracellular ATP, monosodium uric acid (MSU), 
amyloid β, silica, asbestos and cholesterol crystal, leading to 
the secretion of IL-1β (30, 56, 57, 60). Reduced inflam- 
mation was observed in NLRP3-deficient mice responding 
to a variety of sterile stimuli, proposing that NLRP3 in- 
flammasome might be the potential target for treating 
chronic sterile inflammatory diseases. 
Although the activation mechanism of NLRP3 inflam- 
masome is not fully characterized yet, several models have 
been proposed to stimulate NLRP3 in response to diverse 
PAMPs or DAMPs. First model involves the intracellular 
level of potassium. Infections with bacteria secreting 
pore-forming toxins such as listeriolycin, pneumolysin or 
streptolysin O have been shown to activate NLRP3 in- 
flammasome (5). Pore formation might trigger both the 
entry of unknown ligands for NLRP3 and the efflux of 
potassium. Interestingly, extracellular ATP or nigericin has 
been well known to stimulate NLRP3 inflammasome 
through potassium efflux. Although it remains to be deter- 
mined how potassium efflux affects the NLRP3 inflam- 
masome, potassium efflux seems also critical for ASC 
pyroptosome formation or AIM2 inflammasome upon 
infected with Francisella tularensis (27, 61). These obser- 
vations thus suggest that potassium efflux might be the 
common event to trigger inflammasome activation. The 
second model is mediated by lysosomal destabilization. 
Endogenous particulates such as MSU, silica, alum or 
cholesterol crystal, are likely to cause lysosomal rupture 
leading to the cytoplasmic release of lysosomal contents 
including cathepsin B that might activate NLRP3 
inflammasome (58, 60). Seemingly, inhibitor of cathepsin 
B, partially abrogated NLRP3-mediated IL-1β secretion 
upon stimulated with silica, but not with ATP, indicating 
that the release of cathepsin B is responsible for lysosomal 
destabilization-mediated NLRP3 inflammasome activation 
(58). Further study will be needed to clarify how lysosomal 
destabilization triggers the activation of NLRP3 inflam- 
masome. Next model for activation of NLRP3 is mediated 
by the intracellular ROS, produced responding to infection 
or tissue injury. A wide range of PAMPs or DAMPs have 
been shown to induce the production of ROS in an 
NADPH oxidase (NOX)-dependent or mitochondria-
dependent manner (5, 62). It remains poorly defined how 
ROS affects NLRP3 inflammasome, but recent study pro- 
posed that thioredoxin-interacting protein (TXNIP) is 
released from thioredoxin upon oxidative stress and interacts 
with NLRP3 leading to formation of NLRP3 inflammasome 
(63). It will be of interest to investigate whether TXNIP 
could affect other inflammasome component. 
Furthermore, mutations in NLRP3 are more frequently 
found in the patients of hereditary periodic fever syndrome, 
featured by elevated level of IL-1β, proposing that disease-
associated mutants of NLRP3 might be the constitutive 
activator of caspase-1 leading to these disorders such as 
Muckle-Wells Syndrome (MWS), familial cold autoinflam- 
matory syndrome (FCAS) and neonatal-onset multisystem 
inflammatory disease (NOMID). Disease-associated muta- 
tions in NLRP3 might disrupt a potent inhibitory effect of 
LRR motif on the inflammasome assembly, it is still 
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unknown how these mutations are associated with these 
autoinflammatory disorders. Nevertheless, knock-in mice 
harboring Cryopyrin Associated Periodic Syndromes 
(CAPS)-associated mutations in NLRP3 exhibited an 
increase in proinflammatory cytokines including IL-1β and 
an inflammasome-dependent systemic inflammation (64, 
65). Furthermore, mutations in NLRP3 might be involved 
in the susceptibility for more common autoinflammatory 
disease, Crohn's disease (66). These observations will give 
a new insight that constitutive assembly of NLRP3 or other 
inflammasome may be associated with chronic auto- 
inflammatory diseases. 
 
Pyrin inflammasome in 
autoinflammatory syndrome 
 
MEFV gene, which encodes pyrin (marenostrin), was 
identified by positional cloning as a susceptible gene for 
familial Mediterranean fever (FMF), a recessively inherited 
autoinflammatory disorder (67, 68). Pyrin contains N-
terminal PYD, followed by B-box domain, coiled-coil 
domain and SPRY (also known as B30.2) domain. As far, 
more than 80 mutations, in pyrin have been associated with 
the phenotype of FMF (69), however, the molecular 
mechanism of pyrin mutation contributing into this periodic 
fever syndrome is poorly understood. 
Pyrin belongs to a tripartite motif (TRIM)-containing 
protein superfamily, which are induced by type I or II IFN 
to regulate host innate immune response against viral 
infection (70). TRIM family proteins are featured by a 
unique N-terminal RING/B-box/coiled-coil (RBCC) motif 
comprising really-interesting-new-gene (RING) domain, 
B-box domain and coiled-coil domain, followed by diverse 
C-terminal domain as one or combinations of 10 distinct 
domains such as SPRY domain and C-terminal subgroup 
one signature (COS) domain (70). Numerous TRIM mem- 
bers including TRIM5α were shown to interfere with the 
life cycle of infected HIV at different stages (71, 72). 
Interestingly, some TRIM proteins were recently shown to 
regulate TLR- or RLR-mediated anti-viral innate immune 
responses in a positive or negative way. C-terminal SPRY 
domain of TRIM25 binds to CARD of RIG-I, which 
induces ubiquitination of RIG-I, leading to the induction of 
type I IFN signaling (73). Similarly, TRIM56 associates 
with stimulator of interferon genes (STING) to induce 
ubiquitination of STING, consequently resulting in the pro- 
duction of type I IFN in response to cytoplasmic dsDNA 
(74). On the contrary, mouse TRIM30α and TRIM27 were 
reported to inhibit NF-κB- or IRF-mediated proinflam- 
matory gene expression through the interaction with TAK1 
and IKKs (75, 76). These evidences suggest that TRIM 
family, induced by IFN, could play a key role not only in 
restricting a retroviral progression but in regulating PRR-
mediated innate immune responses as a positive or negative 
feedback mechanism. 
Pyrin (TRIM20) is the only TRIM member containing 
N-terminal PYD instead of RING domain. Using a yeast 
two-hybrid screening, ASC was identified to interact with 
pyrin through PYD-PYD homotypic interaction (77). 
However, the physiological function of pyrin in ASC/ 
inflammasome signaling has been debated. Pyrin was first 
proposed to reduce NLRP3-mediated apoptosis and NF-κB 
activation via disrupting the interaction between ASC and 
NLRP3 in a transfection experiment (78). In consistent with 
this observation, mouse macrophages expressing truncated 
pyrin exhibited an increased IL-1β secretion upon stimulated 
with LPS, suggesting that pyrin might act as a negative 
regulator of caspase-1 activation by way of sequestering of 
ASC (79). The inhibitory role of pyrin in inflammasome 
formation was further supported by the following studies 
demonstrating that pyrin directly interacts with caspase-1, 
IL-1β and NLRP3 to inhibit caspase-1 activation and 
knockdown of pyrin leads to a slight increase in IL-1β 
secretion in THP-1 cells stimulated with LPS or MSU (80, 
81). 
On the contrary, a characteristic speck-like structure of 
ASC was clearly observed by the coexpression of pyrin, 
indicating that pyrin is able to oligomerize ASC (77, 79, 
82). In a HEK293T cell-based reconstitution system, pyrin 
was not likely to compete with NLRP3 or caspase-1 for the 
binding to ASC, instead pyrin forms a NLRP3-independent 
molecular assembly with ASC and procaspase-1 leading to 
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caspase-1 activation, proposing pyrin inflammasome hypo- 
thesis (82). This pyrin inflammasome model is consistent 
with the previous report demonstrating both pyrin and 
NLRP3 enhance IL-1β secretion in the presence of ASC 
(83). Seshadri et al. also showed that overexpression of 
pyrin in HEK293 or THP-1 cells increases caspase-1 activa- 
tion and IL-1β secretion in an ASC-dependent manner, and 
knockdown of pyrin suppresses IL-1β release from LPS-
stimulated THP-1 and peripheral blood mononuclear cells 
(84). Notably, upregulated endogenous pyrin by retroviral 
infection is correlated with robust caspase-1 activation and 
IL-1β secretion in THP-1 cells (10). This observation also 
revealed that autoinflammatory Pyogenic sterile Arthritis, 
Pyoderma gangrenosum, and Acne (PAPA) syndrome-
associated mutants of Proline-serine-threonine phosphatase 
interacting protein 1 (PSTPIP1) interact with B-box domain 
of pyrin, and this engagement exposes PYD of pyrin, which 
then bind to PYD of ASC, resulting in the activation of 
caspase-1 (10). These results raise the possibility that pyrin is 
a bona fide inflammasome component to activate caspase-1 
in an ASC-dependent manner. 
Considering that mouse pyrin lacks the C-terminal SPRY 
domain, the most susceptible region for disease-associated 
mutations in the FMF patients, the above discrepancy might 
be arisen from the difference in the presence of SPRY 
domain. To give a molecular insight on the physiological 
role of pyrin, Chae et al. recently developed a knockin 
mouse model to express chimeric pyrin containing C-
terminal human FMF-associated SPRY domain (85). This 
study clearly demonstrated that knockin mice harboring 
chimeric pyrin spontaneously developed inflammatory 
phenotypes in ASC- and IL-1β-dependent way, supporting 
that pyrin could assemble inflammasome complex. However, 
it remains to be characterized how the FMF-associated 
mutations enable pyrin to form inflammasome machinery. 
Single nucleotide missense mutations in the FMF patients 
are more frequently found in SPRY domain indicating this 
domain may exert a critical role in the pathogenesis of 
FMF, but it is largely unknown how these disease-associated 
mutations cause FMF. Considering pyrin is an antiviral 
TRIM family member, it is also possible that pyrin might 
act as a sensor for viral infection through SPRY domain. 
Further study on the physiological ligand for pyrin will 
give an important insight into the molecular mechanism of 
pyrin inflammasome complex. 
 
AIM2 inflammasome: Molecular sensor for 
cytosolic double-stranded DNA 
 
Microbial nucleic acid is an important molecular pattern 
for host innate immune system to distinguish nonself 
pathogenic moiety from self upon microbial infection (86). 
Bacterial DNA was, indeed, shown to induce type I IFN 
response more than 25 years ago, proposing that microbial 
DNA might be immunostimulatory (87). Krieg et al. also 
demonstrated that unmethylated CpG dinucleotides in 
bacterial DNA, but not methylated CpG motif in vertebrate 
DNA, trigger immune responses to produce proinflam- 
matory cytokines or type I IFN (88). In 2000, TLR9, which 
are present within endosomal space, was identified as the 
first receptor for bacterial immunostimulatory DNA con- 
taining unmethylated CpG motif (89). Host DNA is 
normally sequestered inside nucleus or mitochondria, but it 
can be released into cytosol from damaged host cell. 
Similar to the microbial DNA, cytosolic dsDNA from host 
damaged cells was also demonstrated to activate innate 
immune systems in a TLR9-independent pathway, indicating 
that the immune systems are stimulated not only by foreign 
DNA but by host unnecessary DNA (90, 91). 
In recent five years, TLR9-independent cytoplasmic 
DNA sensors mediating type I IFN production or caspase-1 
activation have been extensively identified. DNA-dependent 
activator of Interferon-regulatory factor (DAI), also known 
as DLM-1 or Z DNA binding protein-1 (ZBP1), was first 
proposed to recognize cytosolic dsDNA and induce type I 
IFN production via recruiting Tank-binding kinase-1 
(TBK1) and interferon regulatory factor 3 (IRF3) (92). 
However, MEF cells lacking DAI were still responsive to 
cytoplasmic dsDNA to induce type I IFN response, 
suggesting that DAI is not the only dsDNA sensor (93). 
STING (also known as mitochondrial mediator of IRF3 
activation [MITA] or Endoplasmic Reticulum Interferon 
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Stimulator [ERIS]) was then proposed as a crucial adaptor 
protein mediating type I IFN response upon cytoplasmic 
DNA or RNA (94, 95). It is now evident that STING is 
essential for cytosolic DNA-mediated IFN response and 
for host defense against HSV-1 or VSV infection (96), but 
STING does not directly bind to cytoplasmic nucleic acids. 
It remains to be characterized how upstream DNA sensors 
regulates STING mediating IFN response. In addition, both 
HMGB proteins and interferon, gamma-inducible protein 
16 (IFI16) were also identified to sense cytoplasmic dsDNA 
leading to type I IFN signaling in a STING-dependent 
manner (97, 98). These findings indicate that several 
cytoplasmic DNA sensors are responsible for type I IFN 
response upon virus infection or host DNA release. It will 
be of interest to clarify how the DNA-sensing sentinels are 
orchestrated and involved in the autoimmune diseases such 
as systemic lupus erythematosus. 
Cytoplasmic dsDNA was also shown to induce caspase-1 
activation in an ASC-dependent, but NLRP3-independent 
manner, indicating that unknown dsDNA sensor might be 
present to mediate inflammasome pathway (56, 99). In 
2009, AIM2 was identified as a cytoplasmic dsDNA-sensing 
inflammasome to activate caspase-1 through assembling 
ASC (11~14). AIM2 belongs to a hematopoietic inducible 
nuclear protein (HIN)-200 family protein, which is com- 
prised of N-terminal PYD and C-terminal HIN-200 domain 
containing two oligonucleotide/oligosaccharide-binding fold 
(100). As far, 4 human and 5 mouse HIN-200 members 
were cloned and characterized (101). Among them, only 
AIM2 is a cytosolic protein and able to associate with ASC 
through PYD-PYD interaction (11, 12). AIM2 was also 
shown to bind to dsDNA via HIN-200 domain and this 
engagement unexpectedly induced the oligomerization of 
AIM2, suggesting that dsDNA could act as a platform for 
inflammasome formation (11). Notably, cytosolic DNA 
derived from virus infection or host damaged cell is the first 
identified ligand to interact directly with the inflammasome 
component. 
Cytosolic dsDNA-mediated caspase-1 activation was 
completely abrogated in AIM2-deficient macrophages (61, 
102). Furthermore, mice lacking AIM2 exhibited a defect 
in innate immune responses including the activation of 
inflammasome and the production of IL-18 in response to 
infection of Francisella tularensis or vaccinia virus (61, 
102, 103). AIM2 is thus essential for host protection against 
DNA-releasing pathogen through recognizing directly 
bacterial DNA, which triggers the activation of inflam- 
masome. Interestingly, AIM2-lacking macrophages pro- 
duced more type I IFN upon infected with F. tularensis, 
indicating that cytosolic DNA sensing by AIM2 is not 
involved in the production of type I IFN (61). Nevertheless, 
IRF3- or IFNAR1-deficient macrophages demonstrated a 
defect in caspase-1 activation by F. tularensis infection (61), 
suggesting that type I IFN is required for efficient inflam- 
masome activation against F. tularensis infection, consistent 
with the previous report (104). Further study will be needed 
to describe how IFN enhances the inflammasome activity 
in response to bacterial infection. 
AIM2 was also demonstrated to induce caspase-1-
dependent pyroptotic cell death upon stimulation with 
cytosolic DNA (11). Considering AIM2 gene is known as a 
tumor suppressor gene and frequently silenced by DNA 
methylation, frame shift and missense mutation in many 
tumors, inactivation of AIM2 inflammasome-mediated 
pyroptotic pathway may play a crucial role in developing 
these tumors (11, 105). Mouse HIN-200 member, p202 was 
also shown to inhibit cytosolic DNA-induced caspase-1 
and -3 activation supporting HIN-200 family is a major PRR 
to regulate cytoplasmic DNA-mediated immune response 
(14). The discovery of PYD-containing AIM2 inflamma- 
some may contribute important insights into the role of 
dangerous cytosolic DNA in autoimmune disease or cancer. 
 
Concluding Remarks 
 
Inflammasome complex is increasingly recognized as a 
central guardian against microbial infection or endogenous 
danger signal. ASC is definitely a key adaptor molecule to 
assemble inflammasome complex via recruiting PYD-
containing molecule as described above. PYD of ASC is 
needed for triggering or blocking the formation of ASC 
pyroptosome leading to the processing and activation of 
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caspase-1. Dysregulation of caspase-1 is closely associated 
with several autoinflammatory disorders and chronic in- 
flammatory diseases. Hence, in addition to the production 
of type I IFN and proinflammatory cytokine through TLR- 
and RLR-mediated signaling pathway, the assembly of 
inflammasome complex to regulate caspase-1 activity is an 
essential part to keep cell integrity in response to invading 
pathogen or host damage. 
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